hydration effects glp-1 receptor agonist therapy 2025 Ten Top Tips for the Management of Agonists in Adults within Primary Care UC Davis Health examines systemic

Eli Lilly is developing a next-generation GLP therapy called retatrutide that targets three receptors: GLP-1, GIP, and glucagon

In the post hoc analysis, the researchers used data of over 3,500 participants from the Semaglutide Treatment Effect in People with obesity (STEP) 1, 2, 3 and 5 trials

In the SELECT trial that included over 17,000 patients with obesity and established CV disease, but without diabetes, weekly s.c

Alzheimers disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links

2 Svetlana Mojsov, a chemist at Rockefeller University and pioneer in the field of GLP-1 research, had been studying glucagon for years when she first identified the cleavage sites in preproglucagon that give rise to biologically active GLP-1

You might have seen supplements marketed as natural Ozempic on social media, particularly TikTok